Hanfstein, B., Lauseker, M., Hehlmann, R., Saussele, S., Erben, P., Dietz, C., Fabarius, A., Proetel, U., Schnittger, S., Haferlach, C., Krause, S. W., Schubert, J., Einsele, H., Hänel, M., Dengler, J., Falge, C., Kanz, L., Neubauer, A., Kneba, M., Stegelmann, F., Pfreundschuh, M., Waller, C. F., Spiekermann, K., Baerlocher, G. M., Pfirrmann, M., Hasford, J., Hofmann, W.-K., Hochhaus, A. and Müller, M. C. (2014) “Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib”, Haematologica. Pavia, Italy, 99(9), pp. 1441-1447. doi: 10.3324/haematol.2013.096537.